期刊文献+

早期CRRT干预对腹源性脓毒症患者免疫调节作用的研究 被引量:1

Effect of early CRRT intervention on immunoregulation in patients with abdominal sepsis
下载PDF
导出
摘要 目的观察早期进行连续肾脏替代疗法(continuous renal replacement therapy,CRRT)干预对腹源性脓毒症患者免疫功能的影响。方法取我院ICU 2018年1月至2020年6月的AS患者60例,随机分两组,常规治疗按指南进行;治疗组AKI1级时进行CRRT干预,治疗最少3天,每天至少12小时。对照组则AKI2级或以上时CRRT,方案相同。记录干预前及干预后第7天的感染指标、免疫指标等。统计分析应用SPSS 24.0软件进行t检验。结果治疗组PCT、HLA-DR、CD4+/CD8+等均显著改善(P<0.01)。结论早期CRRT的干预能及时阻断免疫麻痹,减轻炎症反应,改善预后。 Objective:To observe the effect of early CRRT intervention on immune function in patients with abdominal sepsis.Methods:Sixty patients with abdominal sepsis in ICU of our hospital for two and a half years were randomly divided into two groups.The routine treatment was carried out according to the guidelines while the treatment group was given CRRT intervention at AKI level 1,at least 3 days,at least 12 hours a day.In the control group,CRRT was used when AKI was 2 or above.The infection index and immune index were recorded before and 7 days after the intervention.SPSS 24.0 software was used for t test.Results:PCT,HLA-DR,CD4+/CD8+were significantly improved in the treatment group(P<0.01).Conclusion:Early CRRT intervention can block immune paralysis,reduce inflammatory reaction and improve prognosis.
作者 毛克江 雷学智 MAO Ke-jiang;LEI Xue-zhi(Dept.of Critical Care Medicine,First Peoples Hospital,Foshan City 528000,China)
出处 《泰山医学院学报》 CAS 2021年第2期102-104,共3页 Journal of Taishan Medical College
基金 佛山市自筹经费类科技计划项目(编号:2017AB001411)。
关键词 腹源性脓毒症(AS) 持续肾脏替代治疗(CRRT) 早期干预 免疫调节 abdominal sepsis continuous renal replacement therapy(CRRT) early intervention immune regulation
  • 相关文献

参考文献5

二级参考文献73

  • 1华军,李海良.胰腺假性囊肿的形成机制和处理原则[J].医学综述,2005,11(6):519-522. 被引量:11
  • 2苏磊,周殿元,唐柚青,文强,白涛,孟繁苏,唐丽群,段鹏凯.CD14^+单核细胞人白细胞DR抗原在脓毒症早期检测中的临床意义[J].中国危重病急救医学,2006,18(11):677-679. 被引量:21
  • 3章云涛,方强.外科术后危重患者单核细胞HLA-DR表达的临床研究[J].中华外科杂志,2006,44(21):1480-1482. 被引量:5
  • 4VOLK H D,REINKE P,KRAUSCH D,et al.Monocyte deactivation:rationale for a new therapeutic strategy in sepsis[J].Intensive Care Med,1996,22 (Supp 14):S474 -S481.
  • 5LEKKOU A,KARAKANTZA M,MOUZAKI A,et al.Cytokine production and monocyte HLA-DR expression as predictors of outcome for patients with community-acquired severe infections[J].Clin Diagn Lab Immunol,2004,11:161-167.
  • 6CAILLE V,CHICHE J D,NCIRI N,et al.Histocompatibility leukocyte antigen-D related expression is specifically altered and predicts mortality in septic shock but not in other causes of shock[J].Shock,2004,22(6):521 -526.
  • 7YU W K,LI W Q,LI N,et al.Mononuelear histocompstibility leukocyte antigen-DR expression in the early phase of acute pancreatitis[J].Pancreatology,2004,4(3/4):233 -243.
  • 8PERRY S E,MOSTAFA S M,WENSTONE R,et al.Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?[J].Intensive Care Med,2003,29(8):1 245-1 252.
  • 9杨红明,于燕,柴家科,胡森,雷树红,张冬青,陶白江,张国安,贺立新,姚咏明.CD14^+单核细胞人类白细胞抗原DR表达率与脓毒症关系的研究[J].中华烧伤杂志,2007,23(4):272-275. 被引量:10
  • 10Angus D C,Linde-Zwirble,W T,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29:1303-1310.

共引文献125

同被引文献17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部